Nomogram for Visual Acuity Outcome after Plaque Radiotherapy and Prophylactic Intravitreal Bevacizumab for Uveal Melanoma: Clinical Risk Factors

Adapted from Nomogram for Visual Acuity Outcome after Plaque Radiotherapy and Prophylactic Intravitreal Bevacizumab for Uveal Melanoma in 1131 Patients by Dalvin et al. 

Please select applicable risk factors listed below to evaluate for risk of decreased visual acuity.